IP Library › Granted Patent US 12,290,250
Granted Patent B2
US 12,290,250 · App. 17/193,598 · Granted May 6, 2025

Devices and methods for delivering powdered agents

Inventors: Andrew Pic (Northboro, MA); Laurie Lehtinen (Boylston, MA); Ryan Evers (Billerica, MA)
Assignee: Boston Scientific Scimed, Inc.
A61B17/00491A61B2017/00367A61M11/003A61M13/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,250
App. No.
17/193,598
Granted
May 6, 2025
Kind
B2
Abstract

A device for delivering an agent may comprise: a housing defining an enclosure. The housing may be configured to store an agent. The device may further comprise an inlet, in fluid communication with the enclosure, for receiving a flow of pressurized fluid; an outlet in fluid communication with the enclosure; and a filter disposed within the enclosure. Pores of a wall of the filter may be configured such that the fluid is permitted to pass through the pores into a channel defined by an inner surface of the wall. An actuation member may be configured to transition between a first configuration, in which portions of the agent disposed proximally to the actuation member are prevented from passing distally of the actuation member, and a second configuration, in which portions of the agent disposed proximally of the actuation member are capable of passing distally of the actuation member.

Claims (41)

1. A device for delivering an agent, comprising:

a housing defining an enclosure, wherein the housing is configured to store an agent;

an inlet, in fluid communication with the enclosure, for receiving a flow of pressurized fluid;

an outlet in fluid communication with the enclosure;

a filter disposed within the enclosure, wherein a wall of the filter includes a plurality of pores, wherein the pores are configured such that the fluid is permitted to pass through the pores into a channel defined by an inner surface of the wall; and

an actuation member disposed within the enclosure, wherein the actuation member is configured to transition between a first configuration, in which portions of the agent disposed proximally to the actuation member are prevented from passing distally of the actuation member, and a second configuration, in which portions of the agent disposed proximally of the actuation member are capable of passing distally of the actuation member;

wherein the actuation member includes a rotatable shaft, wherein the rotatable shaft includes an opening extending through the rotatable shaft substantially perpendicularly to a longitudinal axis of the rotatable shaft;

wherein in the first configuration, the actuation member is positioned relative to the enclosure with the opening not in fluid communication with the enclosure, such that the agent cannot enter the opening from the enclosure;

wherein in the second configuration, the actuation member is positioned relative to the enclosure with the opening in fluid communication with the enclosure, such that the agent is capable of passing through the opening from the enclosure to enter the outlet.

2. The device of claim 1 , wherein the opening includes a first portion, in which a diameter of the opening tapers radially inward, in a distal direction, relative to a longitudinal axis of the opening, and a second portion, in which the diameter of the opening is constant.

3. The device of claim 2 , wherein the opening includes a third portion, distal to the second portion, in which the diameter of the opening tapers radially outward, in a distal direction, relative to the longitudinal axis of the opening.

4. The device of claim 3 , wherein the channel includes a first portion, in which a diameter of the channel tapers radially inward, in a distal direction, relative to a longitudinal axis of the channel.

5. The device of claim 4 , wherein the first portion of the channel terminates distally in a distal end, and wherein the channel includes a second portion, adjacent to the distal end, in which the diameter of the channel is constant, wherein the second portion of the channel is proximal of the first portion of the opening.

6. The device of claim 5 , wherein the channel includes a third portion, distal to the opening, wherein, in the third portion of the channel, the diameter of the channel tapers radially inward, in the distal direction, relative to the longitudinal axis of the channel.

7. The device of claim 1 , wherein the filter is sintered, includes a porous metal, or includes a lattice printed material.

8. The device of claim 1 , wherein the pores are configured such that the agent is not permitted to pass through the pores.

9. The device of claim 8 , wherein the agent is a powder having a particle diameter between 50 microns and 600 microns, and wherein the pores have a diameter between 2 microns and 100 microns.

10. The device of claim 1 , wherein the fluid is permitted to pass through the outlet in both the first configuration and the second configuration.

11. The device of claim 1 , wherein the fluid exits the filter in a turbulent flow pattern.

12. The device of claim 1 , wherein the rotatable shaft extends through one or more openings defined through one or more sides of the housing, and wherein the pores extend along tortuous paths.

13. The device of claim 12 , wherein the one or more openings are defined by outwardly extending protrusions, wherein the protrusions extend outwardly relative to the housing.

14. The device of claim 1 , wherein the rotatable shaft extends through the filter, wherein the rotatable shaft includes a first end and a second end, wherein the first end and the second end of the rotatable shaft each include a groove, wherein the groove of the first end and the groove of the second end each include a seal.

15. A device for delivering an agent, comprising:

a housing defining an enclosure, wherein the housing is configured to store an agent;

an inlet, in fluid communication with the enclosure, for receiving a flow of pressurized fluid;

a filter disposed within the enclosure, wherein a wall of the filter includes a plurality of pores, wherein the pores are configured such that the flow of fluid is permitted to pass through the pores into a channel defined by an inner surface of the wall, and wherein the pores are configured such that the agent is not permitted to pass through the pores;

an outlet in fluid communication with the channel;

an actuation member disposed within the enclosure, wherein the actuation member is configured to transition between a first configuration and a second configuration, in which the agent is not permitted to pass through the outlet when the actuation member is in the first configuration, and in which the agent is permitted to pass through the outlet when the actuation member is in the second configuration;

wherein the actuation member includes a rotatable shaft having an opening, wherein a longitudinal axis of the rotatable shaft is transverse to a longitudinal axis of the enclosure;

wherein in the first configuration, the actuation member is positioned relative to the enclosure with the opening not in fluid communication with the enclosure, such that the actuation member is configured to prevent the agent from entering the opening from the enclosure;

wherein in the second configuration, the actuation member is positioned relative to the enclosure with the opening in fluid communication with the enclosure, such that the actuation member is configured to allow the agent to pass through the opening from the enclosure to enter the outlet;

wherein the fluid is permitted to pass through the outlet in both the first configuration and the second configuration.

16. The device of claim 15 , wherein fluid from the fluid inlet is only permitted to pass through the outlet after passing through the pores.

17. The device of claim 15 , wherein the opening extends substantially perpendicularly to a longitudinal axis of the rotatable shaft.

18. A device for delivering an agent, comprising:

a housing defining an enclosure and configured to hold a powder, wherein the powder has a particle dimension between 50 microns and 600 microns;

an inlet in fluid communication with the enclosure for receiving a flow of pressurized gas;

a sintered filter disposed within the enclosure, wherein a wall of the filter includes a plurality of pores, wherein the pores are configured such that the gas is permitted to pass through the pores into a channel defined by a surface of the wall, and wherein the pores are configured such that the powder is not permitted to pass through the pores, wherein the pores have a diameter between 2 microns and 100 microns;

an actuation member that includes a rotatable shaft having an opening extending through the rotatable shaft substantially perpendicularly to a longitudinal axis of the rotatable shaft, and wherein, in a first configuration of the rotatable shaft, the agent is not permitted to pass through the opening, and wherein, in a second configuration of the rotatable shaft, the agent is permitted to pass through the opening; and

an outlet in fluid communication with the channel.

19. The medical device of claim 18 , wherein the pores extend along tortuous paths.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2021
From: PIC, ANDREW; LEHTINEN, LAURIE; EVERS, RYAN
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 055516/0190 →
Continuity (2)
Provisional Application 62986352 · Mar 6, 2020
Related Publication 20210275157A1 · Sep 9, 2021
References Cited (185)
US 471854A · Howard · 1892 [cited by applicant]
US 881238A · Hasbrouck · 1908 [cited by applicant]
US 1145520A · Smith · 1915 [cited by applicant]
US 1599959A · Buheiji · 1926 [cited by applicant]
US 1732566A · McKendrick · 1929 [cited by applicant]
US 2151418A · Bolté · 1939 [cited by applicant]
US 2185927A · Shelanski · 1940 [cited by applicant]
US 2478715A · Schmitt · 1949 [cited by applicant]
US 2623519A · Cohen · 1952 [cited by applicant]
US 3669113A · Altounyan et al. · 1972 [cited by applicant]
US 3940061A · Gimple et al. · 1976 [cited by applicant]
US 4184258A · Barrington et al. · 1980 [cited by applicant]
US 4259187A · DeFrank · 1981 [cited by examiner]
US 4427450A · Kostansek · 1984 [cited by applicant]
US 4457329A · Werley et al. · 1984 [cited by applicant]
US 4806167A · Raythatha · 1989 [cited by applicant]
US 5215221A · Dirksing · 1993 [cited by applicant]
US 5231983A · Matson et al. · 1993 [cited by applicant]
US 5273531A · Knoepfler · 1993 [cited by applicant]
US 5312331A · Kneopfler · 1994 [cited by applicant]
US 5312333A · Churinetz et al. · 1994 [cited by applicant]
US 5366122A · Guentert et al. · 1994 [cited by applicant]
US 5445612A · Terakura et al. · 1995 [cited by applicant]
US 5470311A · Setterstrom et al. · 1995 [cited by applicant]
US 5778872A · Fukunaga · 1998 [cited by examiner]
US 5884621A · Matsugi et al. · 1999 [cited by applicant]
US 5951531A · Ferdman et al. · 1999 [cited by applicant]
US 6003512A · Gerde · 1999 [cited by applicant]
US 6484750B1 · Foos et al. · 2002 [cited by applicant]
US 6553987B1 · Davies · 2003 [cited by examiner]
US 6554022B2 · Wakeman · 2003 [cited by applicant]
US 6589087B2 · Mackal et al. · 2003 [cited by applicant]
US 6684917B2 · Zhu et al. · 2004 [cited by applicant]
US 6708712B2 · Wakeman · 2004 [cited by applicant]
US 6716190B1 · Glines et al. · 2004 [cited by applicant]
US 6799571B1 · Hughes et al. · 2004 [cited by applicant]
US 7178547B2 · Mackal · 2007 [cited by applicant]
US 7311270B2 · Kapila · 2007 [cited by applicant]
US 7334598B1 · Hollars · 2008 [cited by applicant]
US 7361300B2 · Kelly et al. · 2008 [cited by applicant]
US 7427607B2 · Suzuki · 2008 [cited by applicant]
US 7455248B2 · Kablik et al. · 2008 [cited by applicant]
US 7461649B2 · Gamard et al. · 2008 [cited by applicant]
US 7544177B2 · Gertner · 2009 [cited by applicant]
US 7563299B2 · Baptista da Costa et al. · 2009 [cited by applicant]
US 7673647B2 · Mackal · 2010 [cited by applicant]
US 7841338B2 · Dunne et al. · 2010 [cited by applicant]
US 7892205B2 · Palasis et al. · 2011 [cited by applicant]
US 7921874B2 · Tekulve et al. · 2011 [cited by applicant]
US 8037880B2 · Zhu et al. · 2011 [cited by applicant]
US 8097071B2 · Burgess et al. · 2012 [cited by applicant]
US 8118777B2 · Ducharme et al. · 2012 [cited by applicant]
US 8269058B2 · McCarthy et al. · 2012 [cited by applicant]
US 8313474B2 · Campbell et al. · 2012 [cited by applicant]
US 8360276B2 · Rogier et al. · 2013 [cited by applicant]
US 8361054B2 · Ducharme et al. · 2013 [cited by applicant]
US 8496189B2 · Lomond et al. · 2013 [cited by applicant]
US 8673065B2 · Burgess et al. · 2014 [cited by applicant]
US 8721582B2 · Ji · 2014 [cited by applicant]
US 8728032B2 · Ducharme et al. · 2014 [cited by applicant]
US 8741335B2 · McCarthy · 2014 [cited by applicant]
US 8827980B2 · Ji · 2014 [cited by applicant]
US 8910627B2 · Iwatschenko et al. · 2014 [cited by applicant]
US 8951565B2 · McCarthy · 2015 [cited by applicant]
US 9028437B2 · Ott et al. · 2015 [cited by applicant]
US 9089658B2 · Dunne et al. · 2015 [cited by applicant]
US 9101744B2 · Ducharme · 2015 [cited by applicant]
US 9107668B2 · Melsheimer et al. · 2015 [cited by applicant]
US 9132206B2 · McCarthy · 2015 [cited by applicant]
US 9204957B2 · Gregory et al. · 2015 [cited by applicant]
US 9205170B2 · Lucchesi et al. · 2015 [cited by applicant]
US 9205207B2 · Ji · 2015 [cited by applicant]
US 9205240B2 · Greenhalgh et al. · 2015 [cited by applicant]
US 9308584B2 · Burgess et al. · 2016 [cited by applicant]
US 9310812B2 · Costle et al. · 2016 [cited by applicant]
US 9375533B2 · Ducharme et al. · 2016 [cited by applicant]
US 9492646B2 · Hoogenakker et al. · 2016 [cited by applicant]
US 9517976B2 · Mackal · 2016 [cited by applicant]
US 9545490B2 · Iwatschenko et al. · 2017 [cited by applicant]
US 9555185B2 · Foster et al. · 2017 [cited by applicant]
US 9629966B2 · Ji · 2017 [cited by applicant]
US 9636470B2 · Pohlmann et al. · 2017 [cited by applicant]
US 9707359B2 · Kubo · 2017 [cited by applicant]
US 9713682B2 · Eistetter et al. · 2017 [cited by applicant]
US 9717897B2 · Rogier · 2017 [cited by applicant]
US 9821084B2 · Diegelmann et al. · 2017 [cited by applicant]
US 9839772B2 · Ducharme · 2017 [cited by applicant]
US 9839774B2 · Bonaldo · 2017 [cited by applicant]
US 9846439B2 · Carman et al. · 2017 [cited by applicant]
US 9867931B2 · Gittard · 2018 [cited by applicant]
US 9976660B2 · Stanton et al. · 2018 [cited by applicant]
US 10004690B2 · Lee et al. · 2018 [cited by applicant]
US 10010705B2 · Greenhalgh et al. · 2018 [cited by applicant]
US 10017231B2 · Fawcett, Jr. · 2018 [cited by applicant]
US 10036617B2 · Mackal · 2018 [cited by applicant]
US 10065004B2 · Eder et al. · 2018 [cited by applicant]
US 10173019B2 · Kaufmann et al. · 2019 [cited by applicant]
US 10384049B2 · Stanton et al. · 2019 [cited by applicant]
US 10463811B2 · Lee et al. · 2019 [cited by applicant]
US 10507293B2 · Goodman et al. · 2019 [cited by applicant]
US 10646706B2 · Rogier · 2020 [cited by applicant]
US 10730595B2 · Fawcett · 2020 [cited by applicant]
US 10751523B2 · Rogier · 2020 [cited by applicant]
US 10806853B2 · Gittard · 2020 [cited by applicant]
US 10850814B2 · Fawcett · 2020 [cited by applicant]
US 10994818B2 · Hernandez · 2021 [cited by applicant]
US 20040107963A1 · Finlay et al. · 2004 [cited by applicant]
US 20040249359A1 · Palasis et al. · 2004 [cited by applicant]
US 20050121025A1 · Gamard et al. · 2005 [cited by applicant]
US 20050147656A1 · McCarthy et al. · 2005 [cited by applicant]
US 20050220721A1 · Kablik et al. · 2005 [cited by applicant]
US 20060004314A1 · McCarthy et al. · 2006 [cited by applicant]
US 20060213514A1 · Price et al. · 2006 [cited by applicant]
US 20070056586A1 · Price et al. · 2007 [cited by applicant]
US 20070066920A1 · Hopman et al. · 2007 [cited by applicant]
US 20070066924A1 · Hopman et al. · 2007 [cited by applicant]
US 20070082023A1 · Hopman et al. · 2007 [cited by applicant]
US 20070125375A1 · Finlay et al. · 2007 [cited by applicant]
US 20070151560A1 · Price et al. · 2007 [cited by applicant]
US 20070083137A1 · Hopman et al. · 2007 [cited by applicant]
US 20070199824A1 · Hoerr et al. · 2007 [cited by applicant]
US 20080021374A1 · Kawata · 2008 [cited by applicant]
US 20080287907A1 · Gregory et al. · 2008 [cited by applicant]
US 20090101144A1 · Gamard et al. · 2009 [cited by applicant]
US 20090155342A1 · Diegemann et al. · 2009 [cited by applicant]
US 20090281486A1 · Ducharme · 2009 [cited by applicant]
US 20100121261A1 · Kablik et al. · 2010 [cited by applicant]
US 20100305505A1 · Ducharme et al. · 2010 [cited by applicant]
US 20110073200A1 · Overvaag et al. · 2011 [cited by applicant]
US 20110274726A1 · Guo et al. · 2011 [cited by applicant]
US 20110308516A1 · Price et al. · 2011 [cited by applicant]
US 20140222067A1 · Ericson et al. · 2014 [cited by applicant]
US 20140271491A1 · Gittard et al. · 2014 [cited by applicant]
US 20150094649A1 · Gittard · 2015 [cited by applicant]
US 20150125513A1 · McCarthy · 2015 [cited by applicant]
US 20160375202A1 · Goodman · 2016 [cited by examiner]
US 20170106181A1 · Bonaldo et al. · 2017 [cited by applicant]
US 20170232141A1 · Surti et al. · 2017 [cited by applicant]
US 20170252479A1 · Ji et al. · 2017 [cited by applicant]
US 20170296760A1 · Lee et al. · 2017 [cited by applicant]
US 20180099088A1 · Gittard · 2018 [cited by applicant]
US 20180193574A1 · Smith · 2018 [cited by examiner]
US 20180214160A1 · Hoskins et al. · 2018 [cited by applicant]
US 20180339144A1 · Greenhalgh et al. · 2018 [cited by applicant]
US 20190134366A1 · Erez et al. · 2019 [cited by applicant]
US 20190217315A1 · Maguire et al. · 2019 [cited by applicant]
US 20190232030A1 · Pic et al. · 2019 [cited by applicant]
US 20210024187A1 · Fawcett et al. · 2021 [cited by applicant]
US 20210069485A1 · Rogier · 2021 [cited by applicant]
CN 101401956B · 2012 [cited by applicant]
DE 60215438T2 · 2007 [cited by applicant]
EP 3225172A1 · 2017 [cited by applicant]
EP 3052168B1 · 2019 [cited by applicant]
JP H07118305A · 1995 [cited by applicant]
JP 2017176713A · 2017 [cited by applicant]
JP 2019092645A · 2019 [cited by applicant]
JP 2020503145A · 2020 [cited by applicant]
WO 03013552A1 · 2003 [cited by applicant]
WO 2004066806A2 · 2004 [cited by applicant]
WO 2005062896A2 · 2005 [cited by applicant]
WO 2006071649A2 · 2006 [cited by applicant]
WO 2006088912A2 · 2006 [cited by applicant]
WO 2008033462A2 · 2008 [cited by applicant]
WO 2009061409A1 · 2009 [cited by applicant]
WO 2015050814A1 · 2015 [cited by applicant]
WO 2016209442A1 · 2016 [cited by applicant]
WO 2018157772A1 · 2018 [cited by applicant]
WO 2020009102A1 · 2020 [cited by applicant]
Bridevaux, Pierre-Olivier, et al. “Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study.” European Respiratory Journal 38.4 (2011):… [cited by applicant]
Giday, Samuel, et al. “Safety analysis of a hemostatic powder in a porcine model of acute severe gastric bleeding.” Digestive diseases and sciences 58.12 (2013): 3422-3428. [cited by applicant]
Giday, Samuel A., et al. “A long-term randomized controlled trial of a novel nanopowder hemostatic agent for control of severe upper gastrointestinal bleeding in a porcine model.” Gastrointestinal Endoscopy 69.5 (2009):… [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
Regalia, Kristen, et al. “Hemospray in Gastrointestinal Bleeding.” Practical Gastroenterology. Endoscopy: Opening New Eyes, ser. 8, May 2014, pp. 13-24. 8. [cited by applicant]
Cook Medical. Hemospray Endoscopic Hemostat, COOK, 2014. (7 pages, in English). [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v1”, Cook Medical, 2012. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v2”, Cook Medical, 2013. [cited by applicant]
“Hemospray Clinical Experience Shows Efficacy of a New Hemostasis Modality—v3”, Cook Medical, 2014. [cited by applicant]
Aslanian, Harry R., and Loren Laine. “Hemostatic powder spray for GI bleeding.” Gastrointestinal endoscopy 77.3 (2013): 508-510. [cited by applicant]
Giday, S. A., et al. “Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.” Endoscopy 43.04 (2011): 296… [cited by applicant]
RETSCH GmbH Haan. Sieve Analysis: Taking a Close Look at Quality, An Expert Guide to Particle Size Analysis. 2015. (56 pages, in English). [cited by applicant]
Micromeritics. Density Analysis, 2001. (6 pages, in English). [cited by applicant]
Micromeritics. “Application Note: Bulk and Skeletal Density Computations for the AutoPore.” May 2012. (3 pages, in English). [cited by applicant]
Arefnia, Ali, et al. “Comparative Study on the Effect of Tire-Derived Aggregate on Specific Gravity of Kaolin.” Electronic Journal of Geotechnical Engineering 18 (2013): 335-44. [cited by applicant]
Kesavan, Jana, et al. “Density Measurements of Materials Used in Aerosol Studies”. Edgewood Chemical Biological Center Aberdeen Proving Ground MD, 2000. [cited by applicant]
International Search Report and Written Opinion issued on Jun. 18, 2021 in counterpart International Patent Application No. PCT/US2021/021159 (28 pages, in English). [cited by applicant]